We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZDAI:NASDAQDirectBooking Technology Co., Ltd. Analysis

Data as of 2026-07-11 - not real-time

$1.95

Latest Price

8/10Risk

Risk Level: High

Executive Summary

DirectBooking Technology Co., Ltd. trades at $1.95, well below its DCF‑derived fair value of $7.72, suggesting a sizable discount. However, the stock is battling severe fundamentals – revenue has collapsed by 43%, gross margin sits at just 2.3%, operating margin is –94%, and the company posted a trailing EPS of –$7.41. The balance sheet is strained with a debt‑to‑equity ratio of 84% and a market‑cap of only $15.7 M. Technicals are mixed: price is under both the 20‑day (2.28) and 50‑day (2.26) SMAs, RSI is low at 38 indicating oversold conditions, while MACD remains bearish and volatility is extreme at >100% over 30 days. The market sentiment index reads “Extreme Greed” (94.6), yet the beta of 1.6 points to heightened sensitivity to market swings.
Given the thin trading volume, high beta, and a historic max drawdown of –87%, the stock faces pronounced risk. The lack of dividend, negative cash‑flow generation, and a sector (Engineering & Construction) exposed to regulatory and geopolitical headwinds in Hong Kong further dampen the outlook, despite the apparent price discount.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Bearish MACD and price below short‑term moving averages
  • Oversold RSI suggesting limited upside
  • Extreme price volatility and thin trading volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant valuation gap to DCF fair value
  • Continued negative earnings and high debt load
  • Potential for turnaround if operational restructuring succeeds

Long Term

> 3 years
Cautious
Model confidence: 3/10

Key Factors

  • Sustained revenue decline and negative profit margins
  • High leverage and limited cash generation
  • Elevated sector, regulatory, and geographic risks in Hong Kong

Key Metrics & Analysis

Financial Health

Revenue Growth-43.20%
Profit Margin-81.83%
ROE-207.30%
ROA-60.76%
Debt/Equity84.27
P/B Ratio0.7
Op. Cash Flow$515.1K
Free Cash Flow$5.1M
Industry P/E31.2

Technical Analysis

TrendNeutral
RSI37.9
Support$1.68
Resistance$3.00
MA 20$2.28
MA 50$2.26
MA 200$5.12
MACDBearish
VolumeIncreasing
Fear & Greed Index94.59

Valuation

Fair Value$7.72
GradeUndervalued
TypeValue

Risk Assessment

Beta1.60
Volatility100.69%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.